Suppr超能文献

特立氟胺不会改变神经炎症期间烟酰胺腺嘌呤二核苷酸磷酸氧化酶激活和神经元功能障碍的动态变化。

Teriflunomide Does Not Change Dynamics of Nadph Oxidase Activation and Neuronal Dysfunction During Neuroinflammation.

作者信息

Mothes Ronja, Ulbricht Carolin, Leben Ruth, Günther Robert, Hauser Anja E, Radbruch Helena, Niesner Raluca

机构信息

Institute for Neuropathology, Charité Universitätsmedizin Berlin, Berlin, Germany.

Deutsches Rheumaforschungszentrum - Leibniz Institute, Berlin, Germany.

出版信息

Front Mol Biosci. 2020 Apr 30;7:62. doi: 10.3389/fmolb.2020.00062. eCollection 2020.

Abstract

The multiple sclerosis therapeutic teriflunomide is known to block the synthesis of pyrimidine in mitochondria by inhibiting the enzyme dihydroorotate-dehydrogenase (DHODH). The metabolic processes of oxidative phosphorylation and glycolysis are further possible downstream targets. In healthy adult mice, high levels of dihydroorotate-dehydrogenase (DHODH) activity are measured in the central nervous system (CNS), and DHODH inhibition may cause indirect effects on reactive oxygen species production and NADPH oxidase (NOX) mediated oxidative stress, known to be key aspects of the inflammatory response of the CNS. However, little is known about the effect of teriflunomide on the dynamics of NOX activation in CNS cells and subsequent alterations of neuronal function . In this study, we employed fluorescence lifetime imaging (FLIM) and phasor analysis of the endogeneous fluorescence of NAD(P)H (nicotinamide adenine dinucleotide phosphate) in the brain stem of mice to visualize the effect of teriflunomide on cellular metabolism. Furthermore, we simultaneously studied neuronal Ca signals in transgenic mice with a FRET-based Troponin C Ca sensor based (CerTN L15) quantified using FRET-FLIM. Hence, we directly correlated neuronal (dys-)function indicated by steadily elevated calcium levels with metabolic activity in neurons and surrounding CNS tissue. Employing our intravital co-registered imaging approach, we could not detect any significant alteration of NOX activation after incubation of the tissue with teriflunomide. Furthermore, we could not detect any changes of the inflammatory induced neuronal dysfunction due to local treatment with teriflunomide. Concerning drug safety, we can confirm that teriflunomide has no metabolic effects on neuronal function in the CNS tissue during neuroinflammation at concentrations expected in orally treated patients. The combined endogenous FLIM and calcium imaging approach developed by us and employed here uniquely meets the need to monitor cellular metabolism as a basic mechanism of tissue functions .

摘要

已知多发性硬化症治疗药物特立氟胺可通过抑制二氢乳清酸脱氢酶(DHODH)来阻断线粒体中嘧啶的合成。氧化磷酸化和糖酵解的代谢过程可能是其进一步的下游靶点。在健康成年小鼠中,中枢神经系统(CNS)中可检测到高水平的二氢乳清酸脱氢酶(DHODH)活性,抑制DHODH可能会对活性氧生成和NADPH氧化酶(NOX)介导的氧化应激产生间接影响,而这两者已知是CNS炎症反应的关键方面。然而,关于特立氟胺对CNS细胞中NOX激活动力学及随后神经元功能改变的影响,人们了解甚少。在本研究中,我们利用荧光寿命成像(FLIM)和对小鼠脑干中烟酰胺腺嘌呤二核苷酸磷酸(NAD(P)H)内源性荧光的相量分析来观察特立氟胺对细胞代谢的影响。此外,我们同时使用基于FRET的肌钙蛋白C钙传感器(CerTN L15)在转基因小鼠中研究神经元钙信号,并通过FRET-FLIM进行定量分析。因此,我们将钙水平持续升高所表明的神经元(功能失调)与神经元及周围CNS组织中的代谢活性直接关联起来。采用我们的活体共配准成像方法,在用特立氟胺孵育组织后,我们未检测到NOX激活有任何显著变化。此外,我们也未检测到因局部使用特立氟胺而导致的炎症诱导的神经元功能障碍有任何改变。关于药物安全性,我们可以确认,在口服治疗患者预期的浓度下,特立氟胺在神经炎症期间对CNS组织中的神经元功能没有代谢影响。我们在此开发并采用的内源性FLIM和钙成像相结合的方法独特地满足了监测细胞代谢作为组织功能基本机制的需求。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c04/7203781/ed9babb89cc7/fmolb-07-00062-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验